These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30718416)

  • 1. Design-functionality relationships for adhesion/growth-regulatory galectins.
    Ludwig AK; Michalak M; Xiao Q; Gilles U; Medrano FJ; Ma H; FitzGerald FG; Hasley WD; Melendez-Davila A; Liu M; Rahimi K; Kostina NY; Rodriguez-Emmenegger C; Möller M; Lindner I; Kaltner H; Cudic M; Reusch D; Kopitz J; Romero A; Oscarson S; Klein ML; Gabius HJ; Percec V
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2837-2842. PubMed ID: 30718416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers.
    Miller MC; Ludwig AK; Wichapong K; Kaltner H; Kopitz J; Gabius HJ; Mayo KH
    Biochem J; 2018 Mar; 475(5):1003-1018. PubMed ID: 29321242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
    Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
    Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How presence of a signal peptide affects human galectins-1 and -4: Clues to explain common absence of a leader sequence among adhesion/growth-regulatory galectins.
    Kutzner TJ; Higuero AM; Süßmair M; Kopitz J; Hingar M; Díez-Revuelta N; Caballero GG; Kaltner H; Lindner I; Abad-Rodríguez J; Reusch D; Gabius HJ
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129449. PubMed ID: 31678146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
    André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
    Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Playing Modular Puzzle with Adhesion/Growth-Regulatory Galectins: Design and Testing of a Hybrid to Unravel Structure-Activity Relationships.
    Ludwig AK; Vértesy S; Michalak M; Manning JC; Andre S; Kubler D; Kopitz J; Kaltner H; Gabius HJ
    Protein Pept Lett; 2016; 23(11):1003-1012. PubMed ID: 27697034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1.
    Kutzner TJ; Gabba A; FitzGerald FG; Shilova NV; García Caballero G; Ludwig AK; Manning JC; Knospe C; Kaltner H; Sinowatz F; Murphy PV; Cudic M; Bovin NV; Gabius HJ
    Glycobiology; 2019 Jul; 29(8):593-607. PubMed ID: 31091305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring functional pairing between surface glycoconjugates and human galectins using programmable glycodendrimersomes.
    Xiao Q; Ludwig AK; Romanò C; Buzzacchera I; Sherman SE; Vetro M; Vértesy S; Kaltner H; Reed EH; Möller M; Wilson CJ; Hammer DA; Oscarson S; Klein ML; Gabius HJ; Percec V
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2509-E2518. PubMed ID: 29382751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine homodimeric adhesion/growth-regulatory galectins-1, -2 and -7: comparative profiling of gene/ promoter sequences by database mining, of expression by RT-PCR/immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry.
    Lohr M; Lensch M; André S; Kaltner H; Siebert HC; Smetana K; Sinowatz F; Gabius HJ
    Folia Biol (Praha); 2007; 53(4):109-28. PubMed ID: 17706016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3.
    Weinmann D; Kenn M; Schmidt S; Schmidt K; Walzer SM; Kubista B; Windhager R; Schreiner W; Toegel S; Gabius HJ
    Cell Mol Life Sci; 2018 Nov; 75(22):4187-4205. PubMed ID: 29934665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the glycan specificities of cell-bound human tandem-repeat-type galectin-4, -8 and -9.
    Vokhmyanina OA; Rapoport EM; André S; Severov VV; Ryzhov I; Pazynina GV; Korchagina E; Gabius HJ; Bovin NV
    Glycobiology; 2012 Sep; 22(9):1207-17. PubMed ID: 22547138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells.
    André S; Kaltner H; Lensch M; Russwurm R; Siebert HC; Fallsehr C; Tajkhorshid E; Heck AJ; von Knebel Doeberitz M; Gabius HJ; Kopitz J
    Int J Cancer; 2005 Mar; 114(1):46-57. PubMed ID: 15523676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.
    Smetana K; André S; Kaltner H; Kopitz J; Gabius HJ
    Expert Opin Ther Targets; 2013 Apr; 17(4):379-92. PubMed ID: 23289445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the Structural Significance of Galectin Design by Playing a Modular Puzzle: Homodimer Generation from Human Tandem-Repeat-Type (Heterodimeric) Galectin-8 by Domain Shuffling.
    Ludwig AK; Michalak M; Shilova N; André S; Kaltner H; Bovin NV; Kopitz J; Gabius HJ
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28925965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degraded Arabinogalactans and Their Binding Properties to Cancer-Associated Human Galectins.
    Pfeifer L; Baumann A; Petersen LM; Höger B; Beitz E; Classen B
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary solution structures of galectins-1, -3, and -7.
    Morris S; Ahmad N; André S; Kaltner H; Gabius HJ; Brenowitz M; Brewer F
    Glycobiology; 2004 Mar; 14(3):293-300. PubMed ID: 14693909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates.
    André S; Pieters RJ; Vrasidas I; Kaltner H; Kuwabara I; Liu FT; Liskamp RM; Gabius HJ
    Chembiochem; 2001 Nov; 2(11):822-30. PubMed ID: 11948868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.